Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tornin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Protocols|May 15, 2021
Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell culturesJuan Tornin, Cédric Labay, Francesco Tampieri, et al.
Scientific Reports|July 25, 2019
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in OsteosarcomaJuan Tornin, Miguel Mateu-Sanz, Aida Rodríguez, et al.
Scientific Reports|June 14, 2016
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell PopulationsLucia Martinez-Cruzado, Juan Tornin, Laura Santos, et al.
Cellular and Molecular Life Sciences : CMLS|May 4, 2015
Bone microenvironment signals in osteosarcoma developmentArantzazu Alfranca, Lucia Martinez-Cruzado, Juan Tornin, et al.
Neoplasia (New York, N.Y.)|May 12, 2017
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsLucia Martinez-Cruzado, Juan Tornin, Aida Rodriguez, et al.
Stem Cells (Dayton, Ohio)|July 10, 2013
Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formationRene Rodriguez, Juan Tornin, Carlos Suarez, et al.
Stem Cells International|July 2, 2016
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesAnder Abarrategi, Juan Tornin, Lucia Martinez-Cruzado, et al.
Stem Cells (Dayton, Ohio)|January 22, 2014
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cellsRuth Rubio, Ander Abarrategi, Javier Garcia-Castro, et al.
Oncotarget|April 23, 2016
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaJuan Tornin, Lucia Martinez-Cruzado, Laura Santos, et al.
Journal of Clinical Medicine|April 17, 2019
New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo GrowthVeronica Rey, Sofia T Menendez, Oscar Estupiñan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Protocols|May 15, 2021
Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell culturesJuan Tornin, Cédric Labay, Francesco Tampieri, et al.
Scientific Reports|July 25, 2019
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in OsteosarcomaJuan Tornin, Miguel Mateu-Sanz, Aida Rodríguez, et al.
Scientific Reports|June 14, 2016
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell PopulationsLucia Martinez-Cruzado, Juan Tornin, Laura Santos, et al.
Cellular and Molecular Life Sciences : CMLS|May 4, 2015
Bone microenvironment signals in osteosarcoma developmentArantzazu Alfranca, Lucia Martinez-Cruzado, Juan Tornin, et al.
Neoplasia (New York, N.Y.)|May 12, 2017
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsLucia Martinez-Cruzado, Juan Tornin, Aida Rodriguez, et al.
Stem Cells (Dayton, Ohio)|July 10, 2013
Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formationRene Rodriguez, Juan Tornin, Carlos Suarez, et al.
Stem Cells International|July 2, 2016
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesAnder Abarrategi, Juan Tornin, Lucia Martinez-Cruzado, et al.
Stem Cells (Dayton, Ohio)|January 22, 2014
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cellsRuth Rubio, Ander Abarrategi, Javier Garcia-Castro, et al.
Oncotarget|April 23, 2016
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaJuan Tornin, Lucia Martinez-Cruzado, Laura Santos, et al.
Journal of Clinical Medicine|April 17, 2019
New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo GrowthVeronica Rey, Sofia T Menendez, Oscar Estupiñan, et al.
Pageof 2